Developer of a hydrogel implant for cartilage defect repair. It facilitates the natural repair of cartilage defects in joints. The hydrogel is biocompatible, mimicking natural joint tissue polymers to protect the injured area and encourage healing. It provides a scaffold for the patient cells to regenerate cartilage to alleviate pain and restore joint function. It addresses the significant unmet need for effective cartilage repair, preventing the progression to osteoarthritis. The company was founded in 2014 and headquartered in Enschede, Netherlands. It has raised $15.5M in series b funding, with backing from Brightlands Venture Partners, ReumaNederland, Startupbootcamp, Europa, and others. The company operates in the High Tech - Advanced Materials, Chemicals and Materials Tech - Advanced Materials, Life Sciences - Orthopedics space.
← All startups
Hy2Care
Series BDeveloper of a hydrogel implant for cartilage defect repair. It facilitates the natural repair of cartilage defects in joints. The hydrogel is biocompatible, mimicking natural joint tissue polymers to protect the injured area and encourage healing. It provides a scaffold for the patient cells to regenerate cartilage to alleviate pain and restore joint function. It addresses the significant unmet need for effective…
About
Business model
Advanced Materials > Biomaterials > Biomimetics > Hydrogel,
Orthopedics > Medical Devices > Therapies > Regenerative medicine > Hydrogel Based
Institutional investors
Brightlands Venture PartnersReumaNederlandStartupbootcampEuropaLIOFEuropean Innovation Council
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ See who's investing in High Tech — full fund directory with check size and geography.